The study included 10 adult COVID-19 patients who developed audiovestibular symptoms such as hearing loss, tinnitus or dizziness within three weeks of their COVID-19 diagnosis. Researchers analyzed both human and mouse inner ear tissue, and generated in vitro cellular models of the human inner ear.
They found human inner ear tissue contains the “molecular machinery to allow SARS-CoV-2 entry,” including the ACE2 receptor. Findings also showed the virus can infect hair cells and Schwann cells found in the inner ear.
“Our findings suggest that inner ear infection may underline COVID-19-associated problems with hearing and balance,” researchers said.
To view the full study, click here.
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
